Case File
efta-efta01820370DOJ Data Set 10CorrespondenceEFTA Document EFTA01820370
Date
Unknown
Source
DOJ Data Set 10
Reference
efta-efta01820370
Pages
0
Persons
0
Integrity
Loading PDF viewer...
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
To:
Zelin, Bar
From:
Jeffrey Eps ein
Sent:
Tue 11/24/2OO9 3:24:28 PM
Subject: Re:
it worked,,, check out rothstein epstein florida fraud
On Tuc, Nov 24, 2009 at 1O:21 AM, Zelin, Ba
Hey Boy,
I said a prayer for your well being at the wall, did you feel it?
Barry W. Zelin
Axiom Capital Management
780 Third Avenue, 43rd Floor
NY, NY 1OO17 bzelinaaxiomcapital.00m
OFFICE-
CELL:
FAX:
212-644-6513 wrote:
This email message is for the individual use of the intended recipient's and may contain confidential and privileged information.
Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the
sender by reply email and destroy all copies of the original message. Any views expressed in this message are those of the
individual sender, except where the sender specifically states them to be the views of Axiom Capital Management.
Axiom Capital Management Inc. reviews and archives outgoing and incoming email. Such may be produced at the request of
regulators and/or in connection with judicial/arbitral proceedings. Sender accepts no liability for any errors or omissions arising
as a result of transmission. Use by other than intended recipients is prohibited. This transmission is neither an offer nor a
solicitation of an offer to purchase or liquidate secunties. Opinions or estimates constitute Axiom Capital Management Inc.'s
views, beliefs and judgment at this moment and are subject to change without notice. Information upon which the material
contained in this transmission is based was obtained from sources believed to be reliable but has not been verified. Additional
information is available upon request.
Axiom Capital Management Inc., its affiliates and respective directors, officers and employees may purchase or liquidate securities
mentioned herein as agent or principal.
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
PROT2
PROT0
communication in error, please notify us immediately by return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof, including all attachments.
PROT3
PROT1
Technical Artifacts (3)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.